We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Excretion of 4-Amino-5-Imidazolecarboxamide by Mental Patients

P. L. McGEER, Ph.D., M.D.; E. G. McGEER, Ph.D.; J. E. BOULDING, M.D.
Arch Gen Psychiatry. 1963;8(4):418-422. doi:10.1001/archpsyc.1963.01720100108011.
Text Size: A A A
Published online


Introduction  The ribotide of 4-amino-5-imidazolecarboxamide is a key intermediate in the pathway of purine biosynthesis from glycine to inosinic acid.1 Some breakdown of the ribotide occurs, since the free base (AIC) has been identified in urine both by Vilenkina2 and in this laboratory.3 Our interest in AIC was first aroused by the appearance of an unidentified fading blue spot in chromatograms of extracts of schizophrenic urines sprayed with diazotized sulfanilic acid. After the identification of this spot as AIC, a colorimetric analysis was developed, and a program undertaken to determine its excretion in normal humans and in persons suffering from a variety of mental and physical disorders. Data on AIC excretion in mentally normal humans have been reported previously4,5 and are in general agreement with data obtained by Braunstein and Vilenkina,6,7 using a chromatographic method of analysis. This paper will report the data obtained on AIC excretion by mental patients.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.